XML 132 R63.htm IDEA: XBRL DOCUMENT
v3.23.1

Equity-based participation plans for employees (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Statement [line items] |
Expense related to all equity-based participation and liabilities arising from equity-based payment transactions |
(USD millions) |  | 2022 |  | 2021 |  | 2020 |
Expense related to equity-based participation plans |  | 1 048 |  | 979 |  | 958 |
Liabilities arising from equity-based payment transactions |  | 235 |  | 253 |  | 269 |
Schedule of unvested restricted stock units roll forward |
|  | 2022 |  | 2021 |
|  | Number of shares in millions |  | Weighted average fair value at grant date in USD |  | Number of shares in millions |  | Weighted average fair value at grant date in USD |
Annual Incentive |  |  |  |  |  |  |  |  |
– RSU |  | 0.2 |  | 74.7 |  | 0.2 |  | 87.5 |
– Restricted shares |  | 0.1 |  | 85.0 |  | 0.1 |  | 97.0 |
Share savings plans |  |  |  |  |  |  |  |  |
– RSU |  | 0.4 |  | 75.0 |  | 0.4 |  | 86.9 |
– Shares |  | 1.2 |  | 85.0 |  | 1.1 |  | 97.0 |
Novartis Employee Share Purchase Plan |  | 0.8 |  | 82.8 |  |  |  |  |
Select North America (RSU) |  | 4.9 |  | 74.5 |  | 4.3 |  | 86.9 |
Select outside North America |  |  |  |  |  |  |  |  |
– RSU |  | 2.0 |  | 75.1 |  | 1.8 |  | 86.9 |
– Restricted shares |  | 0.7 |  | 85.0 |  | 0.6 |  | 97.0 |
Long-Term Performance Plan (PSU) |  | 1.7 |  | 82.0 |  | 1.8 |  | 89.5 |
Other share awards |  |  |  |  |  |  |  |  |
– RSU |  | 0.5 |  | 76.3 |  | 0.6 |  | 78.4 |
– Restricted shares |  | 0.1 |  | 86.9 |  |  |  |  |
– Shares |  | 0.1 |  | 86.1 |  | 0.1 |  | 91.9 |
Select outside North America |
Statement [line items] |
Disclosure of number and weighted average remaining contractual life of outstanding share options |
|  | 2022 |  | 2021 |
|  | Options (millions) |  | Weighted average exercise price (USD) |  | Options (millions) |  | Weighted average exercise price (USD) |
Options outstanding at January 1 |  | 1.7 |  | 63.6 |  | 2.6 |  | 62.0 |
Sold or exercised |  | -1.2 |  | 62.6 |  | -0.9 |  | 58.9 |
Outstanding at December 31 |  | 0.5 |  | 66.0 |  | 1.7 |  | 63.6 |
Exercisable at December 31 |  | 0.5 |  | 66.0 |  | 1.7 |  | 63.6 |
Select North America |
Statement [line items] |
Disclosure of number and weighted average remaining contractual life of outstanding share options |
|  | 2022 |  | 2021 |
|  | ADR options (millions) |  | Weighted average exercise price (USD) |  | ADR options (millions) |  | Weighted average exercise price (USD) |
Options outstanding at January 1 |  | 4.0 |  | 64.4 |  | 6.7 |  | 62.9 |
Sold or exercised |  | -2.9 |  | 63.7 |  | -2.7 |  | 60.7 |
Outstanding at December 31 |  | 1.1 |  | 66.1 |  | 4.0 |  | 64.4 |
Exercisable at December 31 |  | 1.1 |  | 66.1 |  | 4.0 |  | 64.4 |

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_StatementLineItems
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |